NXGL: Gunggunge utang jangka dawa NEXGEL Inc.

This chart of the market price for NEXGEL, Inc. (NXGL) is supplemented by long-term debt data, which stands at 0.01. NEXGEL, Inc. (NXGL) ensures the sterile transport of its products to clinics while maintaining strict climate control. Stable revenue is generated through multi-year agreements with pharmacy chains for the supply of hydrogel dressings. Simultaneously, the company is developing new polymer compositions for accelerated tissue healing, which continuously refreshes the product portfolio.

For the long-term investor, the reliability of NEXGEL, Inc. (NXGL) is determined by the balance between expansion and solvency. When analyzing the time series of the organization's long-term financial debt, one must consider the total liabilities with a maturity of more than one year, where an upward trend reflects either the scaling of hydrogel production for the B2B and B2C sectors or the risk of an excessive interest burden that reduces the business's financial independence.